UniProt ID | CHMP7_HUMAN | |
---|---|---|
UniProt AC | Q8WUX9 | |
Protein Name | Charged multivesicular body protein 7 | |
Gene Name | CHMP7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 453 | |
Subcellular Localization | Cytoplasm . Nucleus envelope . Diffused localization, with some punctate distribution, especially in the perinuclear area (PubMed:16856878). Localizes to the nucleus envelope during late anaphase (PubMed:26040712). | |
Protein Description | ESCRT-III-like protein required to recruit the ESCRT-III complex to the nuclear envelope during late anaphase. [PubMed: 26040712 Together with SPAST, the ESCRT-III complex promotes nuclear envelope sealing and mitotic spindle disassembly during late anaphase] | |
Protein Sequence | MWSPEREAEAPAGGDPAGLLPPEWEEDEERMSFLFSAFKRSREVNSTDWDSKMGFWAPLVLSHSRRQGVVRLRLRDLQEAFQRKGSVPLGLATVLQDLLRRGELQRESDFMASVDSSWISWGVGVFLLKPLKWTLSNMLGDNKVPAEEVLVAVELLKEKAEEVYRLYQNSPLSSHPVVALSELSTLCANSCPDERTFYLVLLQLQKEKRVTVLEQNGEKIVKFARGPRAKVSPVNDVDVGVYQLMQSEQLLSRKVESLSQEAERCKEEARRACRAGKKQLALRSLKAKQRTEKRIEALHAKLDTVQGILDRIYASQTDQMVFNAYQAGVGALKLSMKDVTVEKAESLVDQIQELCDTQDEVSQTLAGGVTNGLDFDSEELEKELDILLQDTTKEPLDLPDNPRNRHFTNSVPNPRISDAELEAELEKLSLSEGGLVPSSKSPKRQLEPTLKPL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MWSPEREAEA -----CCCHHHHHCC | 18.65 | 28348404 | |
46 | Phosphorylation | KRSREVNSTDWDSKM HHHCCCCCCCHHHCC | 32.68 | 27251275 | |
84 | Ubiquitination | LQEAFQRKGSVPLGL HHHHHHHCCCCCHHH | 44.76 | - | |
84 | Ubiquitination | LQEAFQRKGSVPLGL HHHHHHHCCCCCHHH | 44.76 | - | |
86 | Phosphorylation | EAFQRKGSVPLGLAT HHHHHCCCCCHHHHH | 24.48 | 20873877 | |
93 | Phosphorylation | SVPLGLATVLQDLLR CCCHHHHHHHHHHHH | 27.13 | 23403867 | |
196 | Phosphorylation | NSCPDERTFYLVLLQ CCCCCHHHHHHHHHH | 18.00 | 23401153 | |
198 | Phosphorylation | CPDERTFYLVLLQLQ CCCHHHHHHHHHHHH | 8.69 | 23401153 | |
219 | Ubiquitination | VLEQNGEKIVKFARG EEEECCCEEEEECCC | 54.95 | - | |
230 | Ubiquitination | FARGPRAKVSPVNDV ECCCCCCCCCCCCCC | 44.52 | - | |
232 | Phosphorylation | RGPRAKVSPVNDVDV CCCCCCCCCCCCCCH | 23.56 | 22617229 | |
242 | Phosphorylation | NDVDVGVYQLMQSEQ CCCCHHHHHHHHHHH | 7.04 | 25850435 | |
245 | Sulfoxidation | DVGVYQLMQSEQLLS CHHHHHHHHHHHHHH | 2.13 | 30846556 | |
247 | Phosphorylation | GVYQLMQSEQLLSRK HHHHHHHHHHHHHHH | 17.22 | 24117733 | |
252 | Phosphorylation | MQSEQLLSRKVESLS HHHHHHHHHHHHHHH | 38.35 | 24117733 | |
254 | Ubiquitination | SEQLLSRKVESLSQE HHHHHHHHHHHHHHH | 47.15 | - | |
257 | Phosphorylation | LLSRKVESLSQEAER HHHHHHHHHHHHHHH | 35.99 | 29507054 | |
259 | Phosphorylation | SRKVESLSQEAERCK HHHHHHHHHHHHHHH | 34.94 | 29507054 | |
337 | Ubiquitination | GALKLSMKDVTVEKA CCEECCCCCCCHHHH | 45.75 | - | |
393 | Ubiquitination | ILLQDTTKEPLDLPD HHHHCCCCCCCCCCC | 60.47 | - | |
405 | Methylation | LPDNPRNRHFTNSVP CCCCCCCCCCCCCCC | 27.81 | - | |
408 | Phosphorylation | NPRNRHFTNSVPNPR CCCCCCCCCCCCCCC | 22.06 | 25159151 | |
410 | Phosphorylation | RNRHFTNSVPNPRIS CCCCCCCCCCCCCCC | 35.57 | 25159151 | |
417 | Phosphorylation | SVPNPRISDAELEAE CCCCCCCCHHHHHHH | 31.86 | 29255136 | |
427 | Ubiquitination | ELEAELEKLSLSEGG HHHHHHHHCCCCCCC | 56.87 | - | |
429 | Phosphorylation | EAELEKLSLSEGGLV HHHHHHCCCCCCCCC | 40.70 | 29255136 | |
431 | Phosphorylation | ELEKLSLSEGGLVPS HHHHCCCCCCCCCCC | 30.71 | 29255136 | |
438 | Phosphorylation | SEGGLVPSSKSPKRQ CCCCCCCCCCCCCCC | 42.81 | 25159151 | |
439 | Phosphorylation | EGGLVPSSKSPKRQL CCCCCCCCCCCCCCC | 30.96 | 25159151 | |
441 | Phosphorylation | GLVPSSKSPKRQLEP CCCCCCCCCCCCCCC | 37.29 | 22617229 | |
449 | Phosphorylation | PKRQLEPTLKPL--- CCCCCCCCCCCC--- | 37.73 | 26074081 | |
451 | Acetylation | RQLEPTLKPL----- CCCCCCCCCC----- | 46.91 | 25953088 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CHMP7_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CHMP7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHMP7_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RHG17_HUMAN | ARHGAP17 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417, AND MASSSPECTROMETRY. |